摘要
目的:研究蒙药润骨灵对小鼠去卵巢绝经后骨质疏松症(Postmenopausal osteoporosis,PMOP)的疗效及作用机制。方法:选取SPF级6月龄未曾交配雌性C57BL/6小鼠70只,去卵巢法(Ovariectomy,OVX)建立小鼠PMOP模型,每组随机10只:正常组(N),假手术组(S),模型组(M),润骨灵高剂量组(RGL-H),润骨灵中剂量组(RGL-M),润骨灵低剂量组(RGL-L),阿仑膦酸钠片组(AS)。N组和S组之外其余组进行双侧卵巢切除术,灌胃治疗12周后,ELISA法检测血清PINP、BALP、β-CTX、TRACP含量,骨组织和肾组织Wnt3a蛋白含量,RT-PCR法对各组小鼠肾及股骨组织中Wnt3a mRNA及β-catenin的表达进行检测。结果:一般情况,N组小鼠活动活跃、机灵、毛发光顺正常;手术各组小鼠精神较为萎靡,术后体重与N组相比明显下降(P<0.05)。治疗后子宫重量,与N组,S组对比模型组及其他给药组有显著差异(P<0.05)。各组小鼠骨密度BMD值、血清PINP、BALP、β-CTX、TRACP、骨组织和肾组织Wnt3a蛋白含量、Wnt3a mRNA及β-cateni蛋白检测结果:与N组和S组比较M组和各给药组均有下降(P<0.05);与M组对比各给药组均有显著差异(P<0.05);与RGL-M组对比RGL-H组,RGL-L组有明显差异(P<0.05);与AS组对比M组,RGL-M组有显著差异(P<0.05);结论:蒙药润骨灵可以改善骨细胞代谢情况,起到预防和治疗绝经后骨质疏松症的作用。
Objective To investigate the effect and mechanism of Mongolian medicine Runguling for Postmenopausal osteoporosis(PMOP)after ovariectomized mice.Methods:Seventy 6-month-old female C57BL/6 mice with SPF grade were selected to study PMOP model with Ovariectomy(OVX),and 10 mice were selected in each group:normal group,sham group,model group,Runguling high-dose group,Runguling medium-dose group,Runguling low-dose group,alendronate sodium tablet group.The other groups except the normal group and the sham group underwent bilateral ovariectomy.After 12 weeks of intragastatic treatment,serum PINP,BALP,β-CTX,TRACP contents,and Wnt3a protein contents in bone and kidney tissues were detected by ELISA.The expression of Wnt3a mRNA andβ-catenin in kidney and femur tissues of mice in each group were detected by RT-PCR.Results:In general,the mice in the normal group were active,clever,smooth and normal.The spirits of the mice in the operation group were lower than those in the normal group(P<0.05).Uterine weight after treatment was significantly different from that of normal group,sham group and model group as well as other administration groups(P<0.05).Bone mineral density BMD,serum PINP,BALP,β-CTX,TRACP,Wnt3a protein content,Wnt3a mRNA andβ-cateni protein content in bone and kidney of mice in each group were decreased compared with normal and sham operation groups(P<0.05).Compared with model group,all administration groups had significant differences(P<0.05).Compared with Runguling medium dose group,Runguling high dose group and Runguling low dose group had significant differences(P<0.05);Compared with alendronate sodium group,Runguling medium dose group had significant difference(P<0.05);Conclusion:Mongolian medicine Runguling can improve bone cell metabolism and play a role in the prevention and treatment of postmenopausal osteoporosis.
作者
乌云必力格
青格勒
斯琴
巴虎山
Wuyunbilige;Qinggele;Siqin;Bahushan(Inner Mongolia Medical University,Hohhot 010107,China;Inner Mongolia International Mongolian Hospital,Hohhot 010010,China)
出处
《中国民族医药杂志》
2024年第9期45-50,共6页
Journal of Medicine and Pharmacy of Chinese Minorities
基金
内蒙古自治区科技转化引导项目:蒙药润骨灵治疗骨质疏松症在临床上的推广应用研究项目编号:2020CG0119
内蒙古自治区公立医院高水平临床专科发展科技项目:蒙药巴特尔-7治疗肠炎相关性脓毒症的临床疗效及作用机制研究,项目编号:2023SGGZ137
内蒙古自治区公立医院高水平临床专科发展科技项目:蒙药巴特尔-7治疗肠炎相关性脓毒症的临床疗效及作用机制研究,项目编号:2023SGGZ137。
关键词
蒙药润骨灵
绝经后骨质疏松症
骨代谢相关蛋白
机制研究
Mongolian medicine Runguling
Postmenopausal osteoporosis
Bone metabolism-related proteins
Mechanism research